Skip to main content

and
  1. No Access

    Article

    Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis

    To meta-statistically compare the efficiency of hypoxia-induced factor prolyl hydroxylase inhibitor on hemoglobin, ferritin, hepcidin rate, and adverse events.

    Min Li, Jiarong Lan, Feixia Dong, Peixin Duan in European Journal of Clinical Pharmacology (2021)